Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;93(12):6778-6781.
doi: 10.1002/jmv.27153. Epub 2021 Aug 12.

Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test

Affiliations

Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test

Nanako Matsuzaki et al. J Med Virol. 2021 Dec.

Abstract

A high-throughput, fully automated antigen detection test for SARS-CoV-2 is a viable alternative to reverse-transcription polymerase chain reaction (RT-qPCR) for mass screening during outbreaks. In this study, we compared RT-qPCR for viral load and the VITROS® SARS-CoV-2 Antigen Test with reference to the results of the LUMIPULSE® SARS-CoV-2 Ag Test. Of 128 nasopharyngeal swab specimens taken from patients suspected of being infected with SARS-CoV-2, 49 were positive and 79 were negative according to RT-qPCR. Consistent dose-dependent detection with VITROS® assay was successfully achieved when using nasopharyngeal swab specimens with Ct values of 32.0 or lesser, whereas the CLEIA-based LUMIPULSE® assay was able to detect lower viral loads compared with the VITROS® assay. Our results show that the performance of the VITROS® assay was satisfactory for the diagnosis of contagious COVID-19 patients in the clinical setting. Highlights The performance of the VITROS® SARS-CoV-2 Antigen Test was sufficient for the diagnosis of contagious COVID-19. This test showed high sensitivity and specificity in the detection of SARS-CoV-2 in samples with a Ct value of 32 or less.

Keywords: CLEIA; COVID-19; RT-qPCR; SARS-CoV-2; nasopharyngeal swab.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
Correlations between Ct values obtained with reverse‐transcription polymerase chain reaction (RT‐qPCR) and antigen levels obtained by each automated antigen‐detection test. The antigen level in (A) the VITROS® SARS‐CoV‐2 Antigen Test and (B) the LUMIPULSE® SASR‐CoV‐2 Ag Test were plotted relative to RT‐qPCR Ct value. The diagonal line shows the cut‐off value

Similar articles

Cited by

References

    1. Lanser L, Bellmann‐Weiler R, Öttl KW, et al. Evaluating the clinical utility and sensitivity of SARS‐CoV‐2 antigen testing in relation to RT‐PCR Ct values. Infection. 2020;13:1‐3. - PMC - PubMed
    1. Tegally H, Wilkinson E, Giovanetti M, et al. Emergence and rapid spread of a new severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) lineage with multiple spike mutations in South Africa. medRxiv. 2020. 10.1101/2020.12.21.20248640 - DOI
    1. Rani PR, Imran M, Lakshmi JV. Symptomatic reinfection of SARS‐CoV‐2 with spike protein variant N440K associated with immune escape. J Med Virol. 2021;93(7):4163‐4165. - PMC - PubMed
    1. Ramírez JD, Muñoz M, Ballesteros N, et al. Phylogenomic evidence of reinfection and persistence of SARS‐CoV‐2: first report from Colombia. Vaccines. 2021;9(3):282. - PMC - PubMed
    1. Centers for Disease Control and Prevention . Duration of isolation and precautions for adults with COVID‐19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Accessed June 29, 2021

MeSH terms